1. Development of an Australian Drug Utilisation Database

   • David J. Edmonds
   • David M. Dumbrell
   • Vasken Demirian

   Guest Editorial 17 November 2012 Pages: 427 - 432

2. Economic Aspects of Pharmacokinetic Services

   • Christopher J. Destache

   Guest Editorial 17 November 2012 Pages: 433 - 436

3. Novel Monoclonal Antiendotoxin Antibody Therapy

   • William K. Fant

   Leading Article 17 November 2012 Pages: 437 - 445

4. Economic and Quality-of-Life Aspects of Treating Small Cell Lung Cancer

   • P. Graham
   • J. Boyages

   Leading Article 17 November 2012 Pages: 446 - 453

5. Decision Analysis in Formulary Decision Making

   • Clyde B. Schechter

   Review Article 17 November 2012 Pages: 454 - 461

6. The Economics of Smoking

   • David Phillips
   • Ichiro Kawachi
   • Murray Tilyard

   Review Article 17 November 2012 Pages: 462 - 470

7. Ondansetron

   • Nelda E. Johnson
   • David B. Nash
   • Catherine J. Sistek

   Original Research Article 17 November 2012 Pages: 471 - 481

8. Omeprazole

   • Lee B. Barradell
   • Donna McTavish

   Pharmacoeconomic Drug Evaluation 17 November 2012 Pages: 482 - 510

9. Evaluating Evaluations of New Health Technologies

   • Jane E. Sisk

   Current Comment 17 November 2012 Pages: 511 - 512